Monday, April 13, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and ...
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2026 Earnings Results on Wednesday, April 22, 2026, after ...
Select findings demonstrate that the use of EXPAREL ® (bupivacaine liposome injectable suspension) in outpatient Total Hip Arthroplasty (THA) ...
Regeneron and Telix to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing model ...
Top insights from the latest market news from Friday, April 10, from The Motley Fool analysts on Team Rule Breakers and Team ...
StockStory.org on MSN
2 small-cap stocks worth investigating and 1 we avoid
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else ...
Cencora has a global brand footprint, a key role in serving specific clinical needs, and profitability, despite thin margins.
In this article, we will look at the stocks Jim Cramer discussed alongside the tech market divide. The host of CNBC’s Mad ...
Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose among different types of injectables and ...
Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and ...
The iShares Future Exponential Technologies ETF is highly sensitive to cost of capital shifts, driven by its tech and ...
Stock futures were little changed ahead of an important inflation reading Friday, while oil prices advanced modestly as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results